Novosanis, Distribuidora GAP Signs Agreement
News Jul 26, 2016
Novosanis has announced a new distribution partnership with Distribuidora GAP short for Distribuidora Química y Hospitalaria GAP. As part of this agreement, Distribuidora GAP will sell the Novosanis’ Colli-PeeTM, a medical device suited for collection of first void urine, in Mexico. Distribuidora GAP is one of Mexico’s largest distributors dedicated to the promotion, sales and distribution of reagents, hospital materials and equipment for clinical laboratories.
“Distribuidora GAP has a strong expertise in the field of distribution of medical devices to labs and hospitals. This distribution partnership will strengthen the international position of Novosanis in Mexico.” says Vanessa Vankerckhoven, CEO Novosanis.
Jesus Ortega Martínez, CEO at Distribuidora GAP: “We’re excited to distribute Colli-PeeTM to laboratories and hospitals in Mexico. Novosanis’ device allows easier and more patient-friendly detection of the Human papillomavirus that can lead to cervical cancer. This is still an important health problem to women living in rural and suburban regions of Mexico. Thanks to Colli-PeeTM we can have new ways to reach out to these remote groups of women. We believe this partnership will help us to fight HPV and save many women from cervical cancer.”
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019
12th International Conference on Cancer Stem Cells and Oncology Research
Jul 18 - Jul 19, 2019
4th Annual Congress on Nanomedicine and Drug Delivery
Apr 04 - Apr 06, 2019